# Re-Engineered Discharge for Diabetes-Computer Adaptive Testing (REDD-CAT)

> **NCT03889600** · NA · WITHDRAWN · sponsor: **Boston Medical Center**

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** REDD-CAT

## Key facts

- **NCT ID:** NCT03889600
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03-02
- **Primary completion:** 2021-04-13
- **Final completion:** 2021-04-13
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was never conducted due to Covid. Key informant interviews were conducted instead.
- **Last updated:** 2023-03-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03889600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03889600, "Re-Engineered Discharge for Diabetes-Computer Adaptive Testing (REDD-CAT)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03889600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*